Back
Protagonist Therapeutics Vs. MicroStrategy Industry Stock Comparison
Sell
33
PTGX
Protagonist Therapeutics
Last Price:
46.45
Seasonality Move:
11.46%
Buy
68
MSTR
MicroStrategy
Last Price:
420.94
Seasonality Move:
28.1%
Sell
33
Protagonist Therapeutics (PTGX)
is a Sell
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $41.65. The Score for PTGX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- PTGX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
68
MicroStrategy (MSTR)
is a Buy
Is MicroStrategy a Buy, Sell or Hold?
- The current MicroStrategy [MSTR] share price is $397.28. The Score for MSTR is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- MSTR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $41.65
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing slight selling pressure.
MSTR Stock Price Chart
What is MicroStrategy's stock price today?
-
The MicroStrategy share price today is $397.28
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MSTR is experiencing selling pressure, which indicates risk of future bearish movement.
PTGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.43 | Sell |
| Relative Strength Index (14 RSI): | 41.01 | Sell |
| Chaikin Money Flow: | -281616 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42.23 - 47.93) | Sell |
| Bollinger Bands (100): | (38.1 - 46.24) | Sell |
MSTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 55.62 | Buy |
| Relative Strength Index (14 RSI): | 65.69 | Buy |
| Chaikin Money Flow: | -68828697 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (215.08 - 361.22) | Buy |
| Bollinger Bands (100): | (112.39 - 257.59) | Buy |
PTGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.17 | Buy |
| 20-day SMA: | 44.7 | Sell |
| 50-day SMA: | 45.23 | Sell |
| 200-day SMA: | 35.68 | Buy |
| 8-day EMA: | 41.66 | Sell |
| 20-day EMA: | 43.5 | Sell |
| 50-day EMA: | 43.92 | Sell |
| 200-day EMA: | 36.78 | Buy |
MSTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 379.97 | Buy |
| 20-day SMA: | 304.96 | Buy |
| 50-day SMA: | 228.27 | Buy |
| 200-day SMA: | 160.2 | Buy |
| 8-day EMA: | 382.76 | Buy |
| 20-day EMA: | 322.54 | Buy |
| 50-day EMA: | 253.5 | Buy |
| 200-day EMA: | 165.86 | Buy |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.45 per share, and a decrease next year of $3.44 per share.
MicroStrategy Earnings Growth & MSTR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $5.75 per share, and an increase next year of $3.05 per share.
Protagonist Therapeutics Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
MicroStrategy Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||